GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 203 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2018. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $43,523,000 | +5961.7% | 639,097 | +3529.2% | 0.20% | +6633.3% |
| Q1 2021 | $718,000 | -78.8% | 17,610 | -77.5% | 0.00% | -80.0% |
| Q4 2020 | $3,385,000 | +33.2% | 78,153 | +69.5% | 0.02% | +50.0% |
| Q3 2020 | $2,542,000 | -47.3% | 46,101 | -39.6% | 0.01% | -58.3% |
| Q2 2020 | $4,820,000 | +883.7% | 76,357 | +695.4% | 0.02% | +700.0% |
| Q1 2020 | $490,000 | -62.8% | 9,600 | -42.0% | 0.00% | -25.0% |
| Q4 2019 | $1,317,000 | -50.7% | 16,565 | -69.9% | 0.00% | -60.0% |
| Q3 2019 | $2,671,000 | +29.8% | 55,053 | +41.6% | 0.01% | +25.0% |
| Q1 2019 | $2,058,000 | +586.0% | 38,887 | +392.2% | 0.01% | +700.0% |
| Q3 2018 | $300,000 | -25.6% | 7,901 | -11.5% | 0.00% | -50.0% |
| Q2 2018 | $403,000 | -71.3% | 8,928 | -69.2% | 0.00% | -66.7% |
| Q1 2018 | $1,402,000 | – | 29,022 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 850,000 | $46,869,000 | 6.00% |
| Asymmetry Capital Management, L.P. | 155,232 | $8,559,000 | 5.50% |
| Grace Capital | 124,749 | $6,878,000 | 5.33% |
| Fernwood Investment Management, LLC | 187,477 | $10,337,000 | 4.88% |
| Perceptive Advisors | 5,800,996 | $319,867,000 | 4.67% |
| ArchPoint Investors | 217,510 | $11,993,000 | 3.83% |
| GREAT POINT PARTNERS LLC | 655,676 | $36,154,000 | 3.25% |
| Profit Investment Management, LLC | 42,196 | $2,328,000 | 1.44% |
| Bain Capital Public Equity Management II, LLC | 381,868 | $21,056,000 | 1.39% |
| Taylor Wealth Management Partners | 52,597 | $2,900,000 | 1.33% |